Rahsaan Thompson

CIK: 0001788524

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (41.7%)

Position reduction

Option Exercises (M)3 (25.0%)

Derivative conversions

Awards (A)4 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ZVRA

ZEVRA THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

ZVRA
ZEVRA THERAPEUTICS, INC.
Aug 14, 2026
Sale(S)
Direct
42.7K shares at avg. $11.13$475K
ZVRA
ZEVRA THERAPEUTICS, INC.
Jun 22, 2026
Sale(S)
Direct
34.6K shares at avg. $12.68$438K
ZVRA
ZEVRA THERAPEUTICS, INC.
Jun 21, 2026
Exercise(M)
Direct
66.7K shares-
ZVRA
ZEVRA THERAPEUTICS, INC.
May 11, 2026
Sale(S)
Direct
1.8K shares at avg. $11.30$20K
ZVRA
ZEVRA THERAPEUTICS, INC.
Jan 30, 2026
Exercise(M)
Direct
11.3K shares-
ZVRA
ZEVRA THERAPEUTICS, INC.
Jan 30, 2026
Sale(S)
Direct
4.1K shares at avg. $8.83$36K
ZVRA
ZEVRA THERAPEUTICS, INC.
Jan 29, 2026
Award(A)
Stock Option (right to buy)
Direct
75K shares-
ZVRA
ZEVRA THERAPEUTICS, INC.
Jan 29, 2026
Award(A)
Restricted Stock Unit
Direct
37.5K shares-
ZVRA
ZEVRA THERAPEUTICS, INC.
Jun 26, 2025
Sale(S)
Direct
24K shares at avg. $9.21$221K
ZVRA
ZEVRA THERAPEUTICS, INC.
Jun 21, 2025
Exercise(M)
Direct
66.7K shares-
ZVRA
ZEVRA THERAPEUTICS, INC.
Jan 30, 2025
Award(A)
Stock Option (right to buy)
Direct
68K shares-
ZVRA
ZEVRA THERAPEUTICS, INC.
Jan 30, 2025
Award(A)
Restricted Stock Unit
Direct
34K shares-

		Type	Shares	Price		Ownership
Aug 14, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Sale(S)	42,666	$11.13	$474,774	Direct
Jun 22, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Sale(S)	34,557	$12.68	$438,304	Direct
Jun 21, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Exercise(M)	66,667	-	$0	Direct
May 11, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Sale(S)	1,794	$11.30	$20,272	Direct
Jan 30, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Exercise(M)	11,333	-	$0	Direct
Jan 30, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Sale(S)	4,080	$8.83	$36,010	Direct
Jan 29, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	75,000	-	-	Direct
Jan 29, 2026	ZVRA ZEVRA THERAPEUTICS, INC.	Award(A) Restricted Stock Unit	37,500	-	-	Direct
Jun 26, 2025	ZVRA ZEVRA THERAPEUTICS, INC.	Sale(S)	24,000	$9.21	$221,004	Direct
Jun 21, 2025	ZVRA ZEVRA THERAPEUTICS, INC.	Exercise(M)	66,666	-	-	Direct
Jan 30, 2025	ZVRA ZEVRA THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	68,000	-	-	Direct
Jan 30, 2025	ZVRA ZEVRA THERAPEUTICS, INC.	Award(A) Restricted Stock Unit	34,000	-	-	Direct

1-12 of 12 transactions

About Thompson Rahsaan

Thompson Rahsaan (SEC CIK 0001788524) files insider reports with the SEC as Chief Legal & Compliance of ZEVRA THERAPEUTICS, INC. (ZVRA).

Signal8 holds 7 ownership filings by Thompson Rahsaan, all Form 4s, filed between Feb 3, 2025 and Aug 17, 2026. Those filings report 12 transactions, from Jan 30, 2025 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Thompson Rahsaan's filings is in BOSTON, MA.

Recent filings by Thompson Rahsaan

Aug 14, 2026: Open-market sale of ZVRA shares (Form 4, code S).
Jun 22, 2026: Open-market sale of ZVRA shares (Form 4, code S).
Jun 21, 2026: Option exercise of ZVRA shares (Form 4, code M).
May 11, 2026: Open-market sale of ZVRA shares (Form 4, code S).
Jan 30, 2026: Option exercise of ZVRA shares (Form 4, code M).

Other insiders filing for ZEVRA THERAPEUTICS, INC. (ZVRA)

McFarlane Neil F., President and CEO
Watton Corey Michael, Director
FAVORITO TAMARA A, Director
Secor Alicia, Director
Calder Douglas W, Director
Anderson Thomas, Director

How to read Form 4 transaction codes